McKesson (MCK) Competitors

McKesson (NYSE:MCK) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Is MCK or HOLX more profitable?

Hologic has a net margin of 13.83% compared to McKesson's net margin of 0.92%. Hologic's return on equity of 19.71% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	0.92%	-201.12%	5.83%
Hologic	13.83%	19.71%	10.87%

Do insiders and institutionals have more ownership in MCK or HOLX?

85.1% of McKesson shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has better valuation & earnings, MCK or HOLX?

McKesson has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$359.05B	0.25	$3.30B	$25.83	27.70
Hologic	$4.03B	3.53	$789.50M	$2.37	26.95

Does the media favor MCK or HOLX?

In the previous week, McKesson had 22 more articles in the media than Hologic. MarketBeat recorded 44 mentions for McKesson and 22 mentions for Hologic. McKesson's average media sentiment score of 1.09 beat Hologic's score of 1.04 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	33 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Hologic	13 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate MCK or HOLX?

McKesson currently has a consensus price target of $710.17, suggesting a potential downside of 0.75%. Hologic has a consensus price target of $77.33, suggesting a potential upside of 21.10%. Given Hologic's higher probable upside, analysts plainly believe Hologic is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86
Hologic	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.47

Which has more risk and volatility, MCK or HOLX?

McKesson has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.

Summary

McKesson and Hologic tied by winning 8 of the 16 factors compared between the two stocks.